evenfolio

FMCG · NSE: MANORAMA

Manorama Industries

Q2 FY27 earnings highlights, from the results presentation

Price as of 16 Nov 2026
1,879.00−5.30%

Q2 FY27 · From the investor presentation

Read the filing on NSEFiling

266​INR MnCapital work in progress · 30 Sep 2026Slides · p. 8
2–3​yearsCapex period · next 2–3 yearsSlides · p. 23
15​MWCaptive solar plant capacitySlides · p. 34
7.4​×Asset turnover · FY26Slides · p. 17
M.Cap
₹11,861Cr
P/E
41.7×
1Y return
+41.36%
From 52W high
−13.1%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue459323+41.9%404+13.6%
EBITDA11888+34.4%106+11.3%
EBITDA margin25.8%27.2%-143 bps26.3%-53 bps
PBTProfit before tax11073+50.5%106+3.6%
Net profit8153+51.8%79+2.7%
EPS (₹)12.448.91+39.6%13.17-5.5%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures. In Q2 FY27 the filing tags the owners' profit as ₹0 Cr against its own period profit; the period profit less minority interest is shown.

More figures from the presentation

Company · Other
1,00,000​beneficiariesJabari Bestaan beneficiaries target
“shea-growing regions with the objective of reaching up to 100,000 beneficiaries through”
Slidesp. 35

In short

  1. 01Q2 FY27 revenue grew 41.9% YoY.
  2. 02Q2 FY27 EBITDA rose 34.4% to Rs 1,182 million and PAT rose 51.8%.
  3. 03H1 FY27 revenue grew 40.8% and PAT grew 59.2%, attributed to demand and a stronger value-added mix.
  4. 04Gross margin fell 577 bps YoY to 42.5% and EBITDA margin was 25.8% in Q2 FY27.
  5. 05Exports were 61% of H1 FY27 revenue.
  6. 06Planned capex over the next 2-3 years covers fractionation debottlenecking and refining, with FY28 target commissioning.

Capex

Plan to add refining capability as forward integration

Slides · p. 23
“02 Scale Refining Add refining capability (forward-integration program)”

FY28 target commissioning for the major projects

Slides · p. 23
“FY28 target commissioning”

Newly acquired land for capex

Slides · p. 22
“NEWLY ACQUIRED LAND FOR CAPEX”

Proposed capex is subject to Board recommended modifications

Slides · p. 23
“^ Subject to Board Recommended Modifications”

Capacity

Focus on turning expanded capacities into sustainable growth

Slides · p. 5
“We are now focused on translating our expanded capacities into sustainable growth, supported”

Plan to debottleneck fractionation capacity

Slides · p. 23
“01 Expand Capacity Debottleneck fractionation capacity”

Segments

Export: Domestic to export revenue mix for H1 FY27 was 39:61

Slides · p. 6
“Geographical Mix: The Domestic to Export Revenue Mix for H1FY27 stood at 39:61.”

Plan to raise share of CBE, stearin, specialty fats and value-added formulations

Slides · p. 23
“Increase contribution from CBE, stearin, specialty fats and application-specific,”

Stearin & CBE: Stearin and CBE were 71.4% of FY26 revenue

Slides · p. 16
“71.4% 2 Decades Fortune 500 FY26 - Stearin & CBE”

Demand

Company cites demand drivers for its specialty fats business

Slides · p. 19
“Strong demand drivers underpin Manorama’s integrated specialty fats proposition”

Margins and costs

Q2 gross margin 42.5% vs 48.3% a year ago, down 577 bps

Slides · p. 7
“Gross Profit margin 42.5% 48.3% -577 bps 43.6% -109 bps 43.0% 47.9% -482 bps 46.3%”

Q2 EBITDA margin 25.8% vs 27.2% a year ago, down 144 bps

Slides · p. 7
“EBITDA margin 25.8% 27.2% -144 bps 26.3% -53 bps 26.0% 26.5% -53 bps 26.4%”

Q2 PAT margin 17.6% vs 16.5% a year ago, up 114 bps

Slides · p. 7
“PAT margin 17.6% 16.5% 114 bps 19.5% -186 bps 18.5% 16.3% 213 bps 16.5%”

Q2 employee expenses INR 216.8 million, up 49.3% YoY

Slides · p. 7
“Employee Expenses 216.8 145.2 49.3% 188.6 14.9% 405.4 328.3 23.5% 723.1”

Debt and working capital

Q2 finance cost INR 113.8 million, up 30.5% YoY

Slides · p. 7
“Finance Cost 113.8 87.2 30.5% 99.0 15.0% 212.8 179.7 18.4% 378.7”

Consolidated total equity INR 13,280 million vs 6,821 million in March

Slides · p. 8
“Total Equity 13,280 6,821”

Consolidated current borrowings INR 4,863 million vs 3,218 million in March

Slides · p. 8
“Borrowings 4,863 3,218 Other Bank Balances”

Consolidated inventories INR 10,012 million vs 7,278 million in March

Slides · p. 8
“Inventories 10,012 7,278”

Consolidated trade receivables INR 1,135 million vs 625 million in March

Slides · p. 8
“Trade Receivables 1,135 625”

Management

Leadership transition described as strengthening governance and management structure

Slides · p. 5
“The leadership transition strengthens Manorama Industries governance and management”

Mudit Kumar Singh listed as Chairman and Whole Time Director

Slides · p. 30
“Mudit Kumar Singh – Chairman & Whole Time Director”

One-offs

Q2 other income INR 96.9 million vs 0.8 million a year ago

Slides · p. 7
“Other Income 96.9 0.8 12,222.0% 161.8 -40.1% 258.7 58.4 342.7% 103.5”

Other

Q2 FY27 revenue grew 41.9% YoY

Slides · p. 5
“We are pleased to report another strong quarter, with Q2FY27 revenue growing 41.9% YoY to”

Q2 EBITDA up 34.4% to ₹1,182 million; PAT up 51.8% to ₹808 million

Slides · p. 5
“₹4,589 million, EBITDA rising 34.4% to ₹1,182 million and PAT increasing 51.8% to ₹808”

H1 FY27 revenue grew 40.8%

Slides · p. 5
“million. H1FY27 performance remained equally robust, with revenue growth of 40.8% and PAT”

H1 PAT growth of 59.2% attributed to demand, value-added mix and execution

Slides · p. 5
“growth of 59.2%, driven by healthy demand, a stronger value-added mix and disciplined”

Q2 diluted EPS INR 12.44 vs 8.91 a year ago

Slides · p. 7
“Diluted EPS (in INR) 12.44 8.91 39.6% 13.17 -5.5% 25.61 16.77 52.7% 37.66”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools